Investments in and Advances to Joint Ventures (Tables)

3 Months Ended

Mar. 31, 2020

Equity Method Investments And Joint Ventures [Abstract]

Schedule of Financial Information of Consolidated Joint Ventures

The following represents financial information for consolidated joint ventures included in the consolidated financial statements (in thousands):

	March 31, 2020		December 31, 2019
Current assets	$	284,357	$	255,167
Noncurrent assets		2,441		2,860
Total assets		286,798		258,027
Current liabilities		219,880		193,583
Total liabilities		219,880		193,583
Total joint venture equity	$	66,918	$	64,444

	Three Months Ended
	March 31, 2020		March 31, 2019
Revenue	$	100,278	$	115,104
Costs		97,150		107,206
Net income	$	3,128	$	7,898
Net income attributable to noncontrolling interests	$	1,398	$	3,645

Summary of Financial Information for Unconsolidated Joint Ventures

The following represents the financial information of the Company’s unconsolidated joint ventures as presented in their unaudited financial statements (in thousands):

	March 31, 2020		December 31, 2019
Current assets	$	735,279	$	801,335
Noncurrent assets		527,529		564,160
Total assets		1,262,808		1,365,495
Current liabilities		663,622		655,495
Noncurrent liabilities		475,463		507,131
Total liabilities		1,139,085		1,162,626
Total joint venture equity		123,723		202,869
Investments in and advances to unconsolidated joint ventures	$	65,716	$	68,620

	Three Months Ended
	March 31, 2020		March 31, 2019
Revenue	$	238,188	$	229,466
Costs		223,686		216,780
Net income	$	14,502	$	12,686
Equity in earnings of unconsolidated joint ventures	$	6,114	$	10,397